You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Potassium Chloride 20meq In Plastic Container patents expire, and when can generic versions of Potassium Chloride 20meq In Plastic Container launch?

Potassium Chloride 20meq In Plastic Container is a drug marketed by Baxter Hlthcare and Otsuka Icu Medcl and is included in two NDAs.

The generic ingredient in POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Potassium Chloride 20meq In Plastic Container

A generic version of POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER?
  • What are the global sales for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER?
Summary for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER
Drug patent expirations by year for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER
Pharmacology for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER

US Patents and Regulatory Information for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 019904-006 Dec 17, 1990 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Otsuka Icu Medcl POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 020161-006 Aug 11, 1998 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 019904-002 Dec 26, 1989 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Potassium Chloride 20mEq in Plastic Container

Last updated: March 12, 2026

What are the current market conditions for potassium chloride 20mEq in plastic containers?

The global potassium chloride market is driven by expanding uses in medical, agricultural, and industrial sectors. The specific formulation of 20mEq in plastic containers primarily targets the pharmaceutical segment, especially intravenous (IV) therapy and electrolyte replenishment.

Market size and growth

  • The global potassium chloride market was valued at approximately USD 3.5 billion in 2022[1].
  • Compound annual growth rate (CAGR) is projected at 4.1% from 2023 to 2030[2].

Pharmaceutical segment focus

  • The intravenous electrolyte replacement segment dominates, with an estimated 55% of total potassium chloride sales.
  • The segment grew at a CAGR of around 3.8% during 2018-2022[3].

Top producers and markets

  • Major producers include Mölnlycke, B. Braun Melsungen, and Baxter International.
  • North America accounts for about 40% of global demand, driven by hospital and clinical settings.
  • Europe and Asia-Pacific follow with growth rates near 4.5% annually.

How does formulation and packaging influence market dynamics?

Formulation specifics

  • The 20mEq dose targets adult IV therapy, balancing efficacy and safety.
  • Patient safety concerns limit dosage variability.

Packaging considerations

  • Plastic containers offer lightweight, cost-effective, and sterile options.
  • Regulatory standards dictate material safety, influencing supplier choices.

What are the competitive and regulatory influences?

Regulatory environment

  • US FDA and European Medicines Agency (EMA) enforce strict standards on IV electrolytes.
  • Good Manufacturing Practice (GMP) compliance is mandatory, impacting manufacturing costs.

Competitive landscape

  • Key players invest in production capacity and formulation innovation.
  • Proprietary packaging and sterilization techniques provide competitive advantages.

Pricing trends

  • Median procurement cost for 20mEq potassium chloride in plastic containers ranges from USD 0.05 to 0.15 per unit (500 mL bag).
  • Price sensitivity exists in hospital procurement, with negotiations lowering costs.

What is the financial outlook?

Revenue projections

  • Potential global sales reach USD 4.5 billion by 2030, considering growth in healthcare infrastructure and electrolyte therapy demand[4].

Profit margins

  • Gross margins are approximately 30-35%, driven by raw material costs and manufacturing efficiencies.
  • R&D expenses are relatively low due to established formulations but may increase with new packaging or safety features.

Investment considerations

  • Supply chain stability, particularly post-pandemic, influences pricing.
  • Innovations in packaging, such as smart containers with usage tracking, could command premium pricing.

How does the product's market trajectory compare to alternatives?

Product Type Market Share (2022) CAGR (2023–2030) Key Advantage
Potassium Chloride in Plastic Containers 65% 4.1% Cost-effective, sterile, lightweight
Multi-dose or glass containers 20% 2.5% Higher durability, reusable
Novel electrolyte solutions 15% 8.0% Improved safety, extended stability

Summary of key market factors

  • Strong demand driven by medical applications.
  • Price competition constrained by regulatory and safety standards.
  • Continuous capacity expansion by main producers.
  • Regulatory compliance impacts cost and time-to-market.
  • Innovation focus lies in safer packaging and delivery mechanisms.

Key Takeaways

  • The potassium chloride 20mEq in plastic container segment shows steady growth within the global electrolyte market.
  • Growth opportunities exist in emerging markets and through technological innovations.
  • Pricing remains competitive but constrained by strict regulatory standards.
  • Investment in production capacity and safety features influences profitability.
  • Market share dominance belongs to established global pharmaceutical companies.

FAQs

What are the primary medical applications for potassium chloride 20mEq in plastic containers?
Electrolyte replacement in IV therapy, addressing hypokalemia, and rehydration protocols.

How does regulatory oversight impact production costs?
Strict GMP compliance raises manufacturing costs but ensures safety and market access.

Are there significant regional differences in market demand?
Yes. North America leads due to hospital infrastructure, while Asia-Pacific exhibits rapid growth driven by developing healthcare systems.

What factors influence pricing fluctuation?
Raw material costs, supply chain stability, regulatory compliance, and competitive negotiations.

Is there potential for packaging innovations to affect market share?
Yes. Smart, safety-enhanced containers may command premium pricing and capture market segments focused on patient safety.


References

[1] MarketsandMarkets. (2022). Potassium Chloride Market Forecast.
[2] Grand View Research. (2023). Electrolyte Solutions Market Analysis.
[3] IQVIA. (2022). Global Pharmaceutical Sales Data.
[4] BCC Research. (2023). Injectable Solutions Market Outlook.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.